| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Gerresheimer AG (XETRA: GXI)
GXI Technical Analysis
5
| As on 18th Jun 2025 GXI STOCK Price closed @ 45.76 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 95.33 & Strong Sell for SHORT-TERM with Stoploss of 97.69 we also expect STOCK to react on Following IMPORTANT LEVELS. |
GXISTOCK Price
| Open | 44.78 | Change | Price | % |
| High | 46.98 | 1 Day | 2.74 | 6.37 |
| Low | 43.86 | 1 Week | -2.36 | -4.90 |
| Close | 45.76 | 1 Month | -13.44 | -22.70 |
| Volume | 648712 | 1 Year | -46.29 | -50.29 |
| 52 Week High 110.30 | 52 Week Low 46.16 | ||||
XETRA Germany Most Active Stocks
| LHAR | 2.05 | -20.23% |
| BBVA | 5.00 | -2.72% |
| BBVA | 5.00 | -2.72% |
| BBVA | 5.00 | -2.72% |
| BVBA | 0.02 | -60.00% |
| SNH | 0.16 | 6.67% |
| SNH | 0.16 | 6.67% |
| SNH | 0.16 | 6.67% |
| AMMN | 8500.00 | 1440578.00% |
| DTE | 30.34 | -0.75% |
XETRA Germany Top Gainers Stocks
XETRA Germany Top Losers Stocks
| GXI Daily Charts |
GXI Intraday Charts |
Whats New @ Bazaartrend |
GXI Free Analysis |
|
|
GXI Important Levels Intraday
| RESISTANCE | 51.77 |
| RESISTANCE | 49.84 |
| RESISTANCE | 48.65 |
| RESISTANCE | 47.46 |
| SUPPORT | 44.06 |
| SUPPORT | 42.87 |
| SUPPORT | 41.68 |
| SUPPORT | 39.75 |
GXI Forecast June 2025
| 4th UP Forecast | 93.26 |
| 3rd UP Forecast | 78.03 |
| 2nd UP Forecast | 68.61 |
| 1st UP Forecast | 59.19 |
| 1st DOWN Forecast | 32.33 |
| 2nd DOWN Forecast | 22.91 |
| 3rd DOWN Forecast | 13.49 |
| 4th DOWN Forecast | -1.74 |
GXI Weekly Forecast
| 4th UP Forecast | 62.43 |
| 3rd UP Forecast | 57.08 |
| 2nd UP Forecast | 53.78 |
| 1st UP Forecast | 50.47 |
| 1st DOWN Forecast | 41.05 |
| 2nd DOWN Forecast | 37.74 |
| 3rd DOWN Forecast | 34.44 |
| 4th DOWN Forecast | 29.09 |
GXI Forecast2025
| 4th UP Forecast | 178.18 |
| 3rd UP Forecast | 135.71 |
| 2nd UP Forecast | 109.46 |
| 1st UP Forecast | 83.21 |
| 1st DOWN Forecast | 8.31 |
| 2nd DOWN Forecast | -17.94 |
| 3rd DOWN Forecast | -44.19 |
| 4th DOWN Forecast | -86.66 |
Gerresheimer AG ( XETRA Germany Symbol : GXI )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
GXI Business Profile
Gerresheimer AG, together with its subsidiaries, manufactures and sells specialty glass, plastic products, and drug delivery-devices and solutions primarily worldwide. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables, and components for dialysis machines, and catheters and surgical devices. It also provides containers for the delivery of tablets and powders, liquid dosages, ophthalmic and rhinological applications, parenteral packaging applications, oral prescription medications, and cosmetics. The Primary Packaging Glass division offers glass primary packaging for pharma and cosmetics industries, such as ampoules, cartridges, vials, syrup and dropper bottles, tablet jars, and wide-neck jars, as well as injection, infusion, and transfusion bottles; flacons and pots for fragrances, deodorants, and care and decorative cosmetics; and bottles and jars for spirits and food. The Advanced Technologies division develops drug delivery products and platforms, such as micro pumps, which are used to self-administer medication for heart failure or Parkinson's for pharmaceutical and biotech customers. The company was founded in 1864 and is headquartered in Düsseldorf, Germany. Address: Klaus-Bungert-Strasse 4, Düsseldorf, Germany, 40468
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service